California Stem Cell Report
Developing ‘revolutionary’ drugs — This company has spent a billion dollars over 25 years and has come up empty. What now?
The enormously expensive task and challenges involved in developing cutting-edge therapies: $12 billion California stem cell and gene therapy program ...
